Mark R. Dyer

436 total citations
9 papers, 359 citations indexed

About

Mark R. Dyer is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, Mark R. Dyer has authored 9 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 1 paper in Surgery and 1 paper in Epidemiology. Recurrent topics in Mark R. Dyer's work include ATP Synthase and ATPases Research (5 papers), Mitochondrial Function and Pathology (4 papers) and RNA and protein synthesis mechanisms (4 papers). Mark R. Dyer is often cited by papers focused on ATP Synthase and ATPases Research (5 papers), Mitochondrial Function and Pathology (4 papers) and RNA and protein synthesis mechanisms (4 papers). Mark R. Dyer collaborates with scholars based in United Kingdom and Switzerland. Mark R. Dyer's co-authors include John E. Walker, Martin F. Bachmann, Paul L. Herrling, Nicholas J. Gay, Steven J. Powell, М. Б. Костина, N Gay, Wolfgang A. Renner, Dalia Cohen and Stephen Joseph Powell and has published in prestigious journals such as Nature Reviews Drug Discovery, Biochemistry and Biochemical Journal.

In The Last Decade

Mark R. Dyer

9 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark R. Dyer United Kingdom 8 252 55 48 35 32 9 359
Merete Rasmussen Denmark 7 339 1.3× 35 0.6× 32 0.7× 18 0.5× 27 0.8× 8 442
Daniel Chauss United States 11 321 1.3× 42 0.8× 30 0.6× 89 2.5× 17 0.5× 24 420
E.P. Adams Australia 10 116 0.5× 179 3.3× 37 0.8× 27 0.8× 19 0.6× 18 377
Leena Harju Finland 5 246 1.0× 20 0.4× 20 0.4× 22 0.6× 82 2.6× 9 380
Youmin Shu United States 9 493 2.0× 200 3.6× 14 0.3× 47 1.3× 25 0.8× 9 634
P.K. Schork United States 4 110 0.4× 70 1.3× 30 0.6× 26 0.7× 41 1.3× 9 308
Christine M. Barbon United States 9 164 0.7× 112 2.0× 136 2.8× 97 2.8× 115 3.6× 15 428
Summar Siddiqui United States 4 195 0.8× 27 0.5× 48 1.0× 24 0.7× 60 1.9× 4 250
Selma Pereira‐Lopes Spain 9 186 0.7× 216 3.9× 35 0.7× 58 1.7× 10 0.3× 9 386
Martijn Schoester Netherlands 11 309 1.2× 38 0.7× 8 0.2× 28 0.8× 20 0.6× 13 484

Countries citing papers authored by Mark R. Dyer

Since Specialization
Citations

This map shows the geographic impact of Mark R. Dyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Dyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Dyer more than expected).

Fields of papers citing papers by Mark R. Dyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Dyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Dyer. The network helps show where Mark R. Dyer may publish in the future.

Co-authorship network of co-authors of Mark R. Dyer

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Dyer. A scholar is included among the top collaborators of Mark R. Dyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Dyer. Mark R. Dyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Dyer, Mark R., Wolfgang A. Renner, & Martin F. Bachmann. (2006). A second vaccine revolution for the new epidemics of the 21st century. Drug Discovery Today. 11(21-22). 1028–1033. 21 indexed citations
2.
Bachmann, Martin F. & Mark R. Dyer. (2003). Therapeutic vaccination for chronic diseases: a new class of drugs in sight. Nature Reviews Drug Discovery. 3(1). 81–88. 88 indexed citations
3.
Dyer, Mark R. & Paul L. Herrling. (2000). Progress and Potential for Gene-Based Medicines. Molecular Therapy. 1(3). 213–224. 30 indexed citations
4.
Dyer, Mark R., Dalia Cohen, & Paul L. Herrling. (1999). Functional genomics: from genes to new therapies. Drug Discovery Today. 4(3). 109–114. 19 indexed citations
5.
Dyer, Mark R. & John E. Walker. (1993). Sequences of members of the human gene family for the c subunit of mitochondrial ATP synthase. Biochemical Journal. 293(1). 51–64. 63 indexed citations
6.
Dyer, Mark R., N Gay, & John E. Walker. (1989). DNA sequences of a bovine gene and of two related pseudogenes for the proteolipid subunit of mitochondrial ATP synthase. Biochemical Journal. 260(1). 249–258. 32 indexed citations
7.
Dyer, Mark R., Nicholas J. Gay, Steven J. Powell, & John E. Walker. (1989). ATP synthase from bovine mitochondria: complementary DNA sequence of the mitochondrial import precursor of the .gamma.-subunit and the genomic sequence of the mature protein. Biochemistry. 28(9). 3670–3680. 21 indexed citations
8.
Walker, John E., Nicholas J. Gay, Steven J. Powell, М. Б. Костина, & Mark R. Dyer. (1987). ATP synthase from bovine mitochondria: sequences of imported precursors of oligomycin sensitivity conferral protein, factor 6, and adenosine triphosphatase inhibitor protein. Biochemistry. 26(26). 8613–8619. 78 indexed citations
9.
Walker, John E., Alison Cozens, Mark R. Dyer, et al.. (1987). Structure and genes of ATP synthase. Biochemical Society Transactions. 15(1). 104–106. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026